BM

Bhawna Mrig

Director Director DIN 01918256
DIN 01918256 First appointment Dec 2007 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 2 historical roles
Total affiliations 2 Since Dec 2007
Shareholding value β€’β€’β€’β€’ Premium profile

About Bhawna Mrig

Data last updated:

Bhawna Mrig was a Director at Winston Pharmaceuticals Limited (2007–2008) and Director at Mrigmen Impex Private Limited (from 2008). The companies operate in Pharma.

DIN 01918256
Primary Designation Director
Industry Pharma
First Appointment 25 Dec 2007
Oldest Company Age 18 yrs

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Winston Pharmaceuticals Limited U24231MH1996PLC360820
Director25 Dec 20071996₹3.85 Cr (FY 2023)Amalgamated
Mrigmen Impex Private Limited U11100UP2008PTC034390
Director07 Jan 20082008Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Mrigmen Impex Private Limited
Winston Pharmaceuticals Limited
Premium access

Shareholding and investment profile for Bhawna Mrig

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Bhawna Mrig

Bhawna Mrig was first appointed on 25 Dec 2007 as Director at Winston Pharmaceuticals Limited. The most recent appointment on record is 07 Jan 2008 at Mrigmen Impex Private Limited.

Bhawna Mrig held 2 earlier board appointments: Winston Pharmaceuticals Limited (Director, 25 Dec 2007 to 28 Jul 2008); Mrigmen Impex Private Limited (Director, from 07 Jan 2008).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available